By Ashley Hayes, CNN
November 25, 2013 -- Updated 2034 GMT (0434 HKT)
(CNN) -- The Food and Drug Administration said Monday that it was loosening restrictions on the controversial diabetes drug Avandia "to reflect new information regarding the cardiovascular risk."
An advisory panel voted in June to recommend loosening restrictions put in place in 2010, when the FDA limited Avandia use to patients with type 2 diabetes who could not control their illness with other medications.
Read more here: http://www.cnn.com.ph/2013/11/25/health/fda-avandia/index.html?hpt=he_c2